A novel disorder reveals clathrin heavy chain-22 is essential for human pain and touch development.

Autor:	Nahorski MS; 1 Cambridge Institute for Medical Research, University of Cambridge, Cambridge, CB2 0XY, UK msn27@cam.ac.uk cw347@cam.ac.uk., Al-Gazali L; 2 Department of Paediatrics, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, UAE., Hertecant J; 3 Department of Paediatrics, Tawam Hospital, Al-Ain, UAE., Owen DJ; 1 Cambridge Institute for Medical Research, University of Cambridge, Cambridge, CB2 0XY, UK., Borner GH; 1 Cambridge Institute for Medical Research, University of Cambridge, Cambridge, CB2 0XY, UK 4 Max Planck Institute of Biochemistry, Department of Proteomics and Signal Transduction, Am Klopferspitz 18, 82152 Martinsried, Germany., Chen YC; 1 Cambridge Institute for Medical Research, University of Cambridge, Cambridge, CB2 0XY, UK., Benn CL; 5 Neusentis, The Portway Building, Granta Park, Cambridge. CB21 6GS, UK., Carvalho OP; 1 Cambridge Institute for Medical Research, University of Cambridge, Cambridge, CB2 0XY, UK., Shaikh SS; 1 Cambridge Institute for Medical Research, University of Cambridge, Cambridge, CB2 0XY, UK., Phelan A; 5 Neusentis, The Portway Building, Granta Park, Cambridge. CB21 6GS, UK., Robinson MS; 1 Cambridge Institute for Medical Research, University of Cambridge, Cambridge, CB2 0XY, UK., Royle SJ; 6 Division of Biomedical Cell Biology, Warwick Medical School, Gibbet Hill Road, Coventry CV4 7AL, UK., Woods CG; 1 Cambridge Institute for Medical Research, University of Cambridge, Cambridge, CB2 0XY, UK msn27@cam.ac.uk cw347@cam.ac.uk.
Jazyk:	angličtina
Zdroj:	Brain : a journal of neurology [Brain] 2015 Aug; Vol. 138 (Pt 8), pp. 2147-60. Date of Electronic Publication: 2015 Jun 11.
DOI:	10.1093/brain/awv149
Abstrakt:	Congenital inability to feel pain is very rare but the identification of causative genes has yielded significant insights into pain pathways and also novel targets for pain treatment. We report a novel recessive disorder characterized by congenital insensitivity to pain, inability to feel touch, and cognitive delay. Affected individuals harboured a homozygous missense mutation in CLTCL1 encoding the CHC22 clathrin heavy chain, p.E330K, which we demonstrate to have a functional effect on the protein. We found that CLTCL1 is significantly upregulated in the developing human brain, displaying an expression pattern suggestive of an early neurodevelopmental role. Guided by the disease phenotype, we investigated the role of CHC22 in two human neural crest differentiation systems; human induced pluripotent stem cell-derived nociceptors and TRKB-dependant SH-SY5Y cells. In both there was a significant downregulation of CHC22 upon the onset of neural differentiation. Furthermore, knockdown of CHC22 induced neurite outgrowth in neural precursor cells, which was rescued by stable overexpression of small interfering RNA-resistant CHC22, but not by mutant CHC22. Similarly, overexpression of wild-type, but not mutant, CHC22 blocked neurite outgrowth in cells treated with retinoic acid. These results reveal an essential and non-redundant role for CHC22 in neural crest development and in the genesis of pain and touch sensing neurons. (© The Author (2015). Published by Oxford University Press on behalf of the Guarantors of Brain.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu